Patents by Inventor Stefan Gabriel Jozef Thoelen

Stefan Gabriel Jozef Thoelen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition
    Patent number: 7144703
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: December 5, 2006
    Assignee: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Michael J Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Novel composition
    Publication number: 20040241193
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Application
    Filed: July 1, 2004
    Publication date: December 2, 2004
    Applicant: SmithKline Beecham Biologicals, s.a.
    Inventors: Claude Artois, Michael J. Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart
  • Novel composition
    Publication number: 20030049268
    Abstract: Novel vaccine compositions are provided comprising a hepatitis B antigen formulated with aluminium phosphate. The vaccine compositions may additionally contain an inactivated hepatitis A virus, aluminium hydroxide and formol. The combined hepatitis A and B vaccine formulations can, if desired, be administered to human subjects in a 2 dose regimen. Suitable formulations are illustrated.
    Type: Application
    Filed: August 20, 2002
    Publication date: March 13, 2003
    Applicant: SmithKline Beecham Biologicals s.a.
    Inventors: Claude Artois, Michael J. Clark, Stefan Gabriel Jozef Thoelen, Clothilde Thiriart